Our Annual Review 2023 is out!
26 March 2024

Our Annual Review 2023 is out!

We are delighted to share with you HIV Outcomes Annual Review 2023! Discover our initiative and delve into our work over the past year, including our biggest achievements, the impactful work of our national initiatives, and a sneak peek into our plans for 2024.

Throughout 2023, we remained focused on ensuring that policymakers pay due attention to and address issues challenging the Health-Related Quality of Life (HRQoL) of people living and ageing with HIV, including stigma, discrimination, and a higher risk of comorbidities.

“Research and policy must walk in the same direction with a common goal: people-centred care and the improvement of the health-related quality of life of people living with HIV.”

Prof. Jeffrey Lazarus, founding Member and previous Co-Chair HIV Outcomes

More updates All

15 November 2024
Insights from the European Parliament's study on Health-related quality of life (HRQoL) for people living with HIV demonstrate that only 13 countries in the WHO Europe Region assess HRQoL as part ...
More
02 August 2024
HIV Outcomes hosted a multi-stakeholder roundtable discussion titled "Fostering Change in Policy and Clinical Practice in Europe" during AIDS 2024 in the Silver Zone. The session featured contributions from several Steering ...
More
12 December 2023
The HIV Outcomes initiative collaborated with MEP Frédérique Ries (Renew Europe Vice-President, Belgium), MEP Sara Cerdas (S&D, Portugal) and MEP Sirpa Pietikäinen (EPP, Finland) to organise ...
More
Month / Year
November 2024 August 2024 March 2024 December 2023 May 2023 February 2023 November 2022 October 2022 September 2022 July 2022 May 2022 April 2022 February 2022 October 2021 June 2021 March 2021 December 2020 October 2020 September 2020 June 2020 April 2020 February 2020 December 2019 November 2019 September 2019 April 2019 December 2018 November 2018 October 2018 November 2017 July 2017 June 2017
Categories
ReportNewsPress Releases
Filters
This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.